O'Shaughnessy Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,705	Closed	-$768K	–	1227
2014 Q4	$768K	Sell	6,705 -2,777	-29%	-$336K	0.01%	352
2014 Q3	$1.48M	Sell	9,482 -5,473	-37%	-$793K	0.03%	285
2014 Q2	$1.84M	Sell	14,955 -3,086	-17%	-$341K	0.03%	266
2014 Q1	$1.87M	Buy	18,041 +6,005	+50%	+$615K	0.04%	254
2013 Q4	$1.08M	Sell	12,036 -1,717	-12%	-$137K	0.02%	312
2013 Q3	$919K	Buy	13,753 +10,679	+347%	+$736K	0.02%	335
2013 Q2	$204K	Buy	+3,074	New	+$176K	0.01%	513

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

O'Shaughnessy Asset Management's SLXP Position: Q1 2015 in Review

O'Shaughnessy Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 6,705 shares — an estimated $768K sold.

O'Shaughnessy Asset Management first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $1.87M in Q1 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

O'Shaughnessy Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
O'Shaughnessy Asset Management sold 6,705 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $768K.
O'Shaughnessy Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
O'Shaughnessy Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.87M in Q1 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2015, filed 6 May 2015.